These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An endogenous inhibitor of platelet MAO activity in chronic schizophrenia: failure to replicate. Wise CD, Potkin S, Bridge P, Wyatt RJ. Am J Psychiatry; 1979 Oct; 136(10):1336-7. PubMed ID: 484736 [No Abstract] [Full Text] [Related]
3. Further studies on the endogenous inhibitor of monoamine oxidase in schizophrenic plasma. Vogel WH, Ladman RK, Berrettini WH. Schizophr Bull; 1980 Oct; 6(2):232-4. PubMed ID: 7375855 [Abstract] [Full Text] [Related]
4. Evidence for an endogenous inhibitor of platelet MAO in chronic schizophrenia. Berrettini WH, Vogel WH. Am J Psychiatry; 1978 May; 135(5):605-7. PubMed ID: 645960 [No Abstract] [Full Text] [Related]
14. Low platelet MAO activity in psychiatric patients and plasma factors: no evidence for inhibitory influences on MAO in the circulating platelet population. Demisch L, Gebhart P, Kaczmarczyk P, von der Mühlen H, Bochnik HJ. Biol Psychiatry; 1981 Jan 15; 16(1):21-33. PubMed ID: 7225472 [Abstract] [Full Text] [Related]
16. Quantitative aspects on mitochondrial monoamine oxidase in human platelets. Wiberg A, Oreland L. Med Biol; 1976 Apr 15; 54(2):137-41. PubMed ID: 1271873 [Abstract] [Full Text] [Related]